These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 15064483)

  • 1. Quality assurance of predictive markers in breast cancer.
    Rhodes A; Barnes DM
    Methods Mol Med; 2004; 97():29-57. PubMed ID: 15064483
    [No Abstract]   [Full Text] [Related]  

  • 2. [Criteria for the use of tumor markers. 1: Quality assurance--characteristics of the most important tumor markers].
    Fateh-Moghadam A; Stieber P
    Fortschr Med; 1996 Feb; 114(6):30-3. PubMed ID: 8900526
    [No Abstract]   [Full Text] [Related]  

  • 3. [Integration of new and future biomarkers in the treatment of breast cancer].
    Würtz SØ; Henriksen KL; Lykkesfeldt A; Celis J; Brünner NA
    Ugeskr Laeger; 2007 Sep; 169(36):2999-3003. PubMed ID: 17953881
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Prognostic and predictive factors in breast cancer].
    Bozhok AA; Semiglazov VF; Semiglazov VV; Arzumanov AS; Klettsel' AE
    Vopr Onkol; 2005; 51(4):434-43. PubMed ID: 16308974
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of predictive values of tumor markers.
    Roulston JE
    Methods Mol Med; 2004; 97():13-27. PubMed ID: 15064482
    [No Abstract]   [Full Text] [Related]  

  • 6. Primary care practice and facility quality orientation: influence on breast and cervical cancer screening rates.
    Goldzweig CL; Parkerton PH; Washington DL; Lanto AB; Yano EM
    Am J Manag Care; 2004 Apr; 10(4):265-72. PubMed ID: 15124503
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Breast cancer--screening data for assessing quality of services--New York, 2000-2003.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2004 Jun; 53(21):455-7. PubMed ID: 15175570
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Revised guidelines signal that gene expression profiles are coming of age.
    Benowitz S
    J Natl Cancer Inst; 2008 Jul; 100(13):916-7. PubMed ID: 18577742
    [No Abstract]   [Full Text] [Related]  

  • 9. [Current technologies of screening for breast cancer].
    Rozhkova NI; Bozhenko VK
    Vopr Onkol; 2009; 55(4):495-500. PubMed ID: 19947380
    [No Abstract]   [Full Text] [Related]  

  • 10. A pathologist's perspective on emerging genomic tests for breast cancer.
    Symmans WF
    Semin Oncol; 2007 Apr; 34(2 Suppl 3):S4-9. PubMed ID: 17512433
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Biological features of breast cancer in patients under 35].
    Damenia AO; Turkevich EA; Semiglazov VF; Kochetova IA; Gurbanov SS; Bit-Sava EM; Efimenko AV
    Vopr Onkol; 2007; 53(6):674-6. PubMed ID: 18416136
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Histologic markers and long-term prognosis in breast cancer.
    Burtness BA
    Cancer J Sci Am; 1997; 3(4):211-2. PubMed ID: 9263626
    [No Abstract]   [Full Text] [Related]  

  • 13. [Prognostic, therapeutic, exploratory tool for carcinogenesis: what is the role of ERBB-2 in breast cancer?].
    Penault-Llorca F; Jacquemier J
    Ann Pathol; 1999 Apr; 19(2):103-15. PubMed ID: 10349474
    [No Abstract]   [Full Text] [Related]  

  • 14. [Diagnostic sensitivity and specificity and positive predictive value in the mass screening for cancer].
    Ohkawa J
    Rinsho Byori; 1988 Jul; 36(7):781-6. PubMed ID: 3236460
    [No Abstract]   [Full Text] [Related]  

  • 15. Biological, biochemical and morphological markers of breast disorders and of breast cancer.
    Leathem AJ
    Acta Histochem Suppl; 1990; 40():51-8. PubMed ID: 2091047
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cancer is heterogeneous.
    Guinebretiere JM
    J Clin Oncol; 2009 Jun; 27(16):2732; author reply 2734-5. PubMed ID: 19380436
    [No Abstract]   [Full Text] [Related]  

  • 17. Absolute risk models for subtypes of breast cancer.
    Gail MH; Anderson WF; Garcia-Closas M; Sherman ME
    J Natl Cancer Inst; 2007 Nov; 99(22):1657-9. PubMed ID: 18000214
    [No Abstract]   [Full Text] [Related]  

  • 18. [Utility and specificity of markers of breast cancer].
    Hurlimann J
    Arch Gynecol Obstet; 1990; 247 Suppl():S86-90. PubMed ID: 2085280
    [No Abstract]   [Full Text] [Related]  

  • 19. Breast cancer testing scandal shines spotlight on black box of clinical laboratory testing.
    Hede K
    J Natl Cancer Inst; 2008 Jun; 100(12):836-7, 844. PubMed ID: 18544732
    [No Abstract]   [Full Text] [Related]  

  • 20. [Predictive and prognostic factors in breast cancer evaluated by immunohistological methods].
    Sinn HP; Magener A; Dürr F; Harcos A; von Minckwitz G
    Verh Dtsch Ges Pathol; 2001; 85():200-5. PubMed ID: 11894398
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.